Category: Research
Denmark: BA.5 up 135% in a month
The latest weekly epidemiological file for Denmark has just been published. More...
Preprint: Long-term mortality following SARS-CoV-2 infection
People infected with SARS-COV-2 had more than three times the risk of dying over the following year compared with those who remained uninfected. More...
SARS-CoV-2 Infection and Persistence Throughout the Human Body and Brain
A video presentation of the recent study entitled “SARS-CoV-2 Infection and Persistence Throughout the Human Body and Brain”. More...
Dr. John Campbell: Wuhan Institute of Virology were working on Monkeypox virus in February 2022
Dr John Campbell wonders why the Wuhan Institute of Virolgy were researching the Monkeypox virus just weeks before the outbreak of Monkeypox in Europe. More...
WHO: We don’t know if it’s too late to contain Monkeypox
“We don’t really know whether it is too late to contain Monkeypox”
The fact that this virus has appeared in Europe in a large number of cases, an increasing number of cases, is clearly cause for some concern and it does suggest that there may have been undetected transmission for a while. More...
Preprint: COVID-19 vaccination and Guillain-Barré syndrome
“Our study reports an association between first-dose ChAdOx1 nCoV-19 (AstraZeneca) COVID-19 vaccination and Guillain-Barré syndrome, accounting for an estimated excess incidence of 5.8 Guillain-Barré syndrome cases per million first doses.” More...
UK: 2 million people suffering with Long Covid
An estimated 2 million people living in private households in the UK (3.1% of the population) were experiencing self-reported long COVID as of 1 May 2022. More...
Monkeypox: 86% of UK cases are in London
Of 190 confirmed cases identified from 6 to 30 May, 183 were in England, 4 were in Scotland, 2 were in Northern Ireland and 1 was in Wales. More...
UK: Principles for monkeypox control
The UKHSA has issued new guidance on the control, transmission and biology of Monkeypox cases. More...
Monkeypox remains viable in aeorosol for up to 90 hours
Monkeypox is resistant to degradation when in aerosol, remaining viable in suspension for up to 90 hours. More...